SLFA - Overview: Cryptococcus Antigen Screen with Titer, Serum

Aiding in the diagnosis of cryptococcosis This test should not be used as a test of cure or to guide treatment decisions. This test should not be used as a screening procedure for the general populations.

CHF8 - Overview: Chromogenic Factor VIII Activity Assay, Plasma

Monitoring coagulation factor replacement therapy of selected extended half-life coagulation factor replacements Aiding in the diagnosis of hemophilia A using a 2-stage assay, especially when the 1-stage assay result was normal

OXCO1 - Overview: Oxalate, Random, Urine

Monitoring therapy for kidney stones Identifying increased urinary oxalate as a risk factor for stone formation Diagnosis of primary or secondary hyperoxaluria

EZNT8 - Overview: Zinc Transporter 8 (ZnT8) Antibody, Serum

Clinical distinction of type 1 from type 2 diabetes mellitus Identification of individuals at risk of type 1 diabetes (including high-risk relatives of patients with diabetes, and those with gestational diabetes) Prediction of future need...

PLAIF - Overview: Phospholipase A2 Receptor (PLA2R), Renal Biopsy

Distinguishing primary membranous nephropathy from secondary membranous nephropathy

FLUOX - Overview: Fluoxetine, Serum

Monitoring serum concentration of fluoxetine during therapy Evaluating potential toxicity Evaluating patient compliance

LACO - Overview: Lacosamide, Serum

Monitoring serum concentrations of lacosamide to ensure compliance and appropriate dosing in specific clinical conditions (ie, severe kidney impairment, mild-to-moderate hepatic impairment, and kidney failure)

AC1Q - Overview: Anti-C1q Antibodies, IgG, Serum

Evaluating patients with suspected anti-C1q vasculitis Predicting renal involvement in patients with systemic lupus erythematosus Detection of anti-C1q antibodies in serum

F_12 - Overview: Coagulation Factor XII Activity Assay, Plasma

Diagnosing deficiency of coagulation factor XII Determining cause of prolonged activated partial thromboplastin time

F_11 - Overview: Coagulation Factor XI Activity Assay, Plasma

Diagnosing deficiency of coagulation factor XI Investigating prolonged activated partial thromboplastin time

OSM24 - Overview: Osmolality, 24 Hour, Urine

Assessing the concentrating and diluting ability of the kidney using a 24-hour urine collection

CL_F - Overview: Chloride, Feces

Workup of cases of chronic diarrhea Evaluation of suspected chloridorrhea

DULOX - Overview: Duloxetine, Serum

Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance

SDLDL - Overview: Small Dense Low Density Lipoprotein Cholesterol, Serum

Aiding in risk management of lipoprotein disorders associated with cardiovascular disease when used in conjunction with other lipid measurements and clinical evaluation

1A2Q - Overview: Cytochrome P450 1A2 Genotype, Varies

Identifying individuals who are poor, intermediate, normal (extensive) or rapid metabolizers of drugs metabolized by cytochrome P450 1A2 to assist drug therapy decision making

8INHE - Overview: Factor VIII Inhibitor Evaluation, Plasma

Detecting the presence and titer of a specific factor inhibitor directed against coagulation factor VIII This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating...

FCXCL - Overview: CXCL9

CXCL9

LPA3P - Overview: Lymphocyte Proliferation to Anti-CD3/Anti-CD28 and Anti-CD3/Interleukin-2 (IL-2), Flow Cytometry, Blood

A second-level test after lymphocyte proliferation to mitogens (specifically phytohemagglutinin) has been assessed Evaluating patients suspected of having impairment in cellular immunity Evaluation of T-cell function in patients with...

PRAME - Overview: PRAME Immunostain, Technical Component Only

Differentiation between melanoma and benign nevi.

LFABP - Overview: Liver Fatty Acid-Binding Protein (L-FABP) Immunostain, Technical Component Only

Classification of hepatic adenomas

BHSF - Overview: Beta-Human Chorionic Gonadotropin, Quantitative, Spinal Fluid

Aiding in the diagnosis of brain metastases of testicular cancer or extragonadal intracerebral germ cell tumors

MYC - Overview: MYC Immunostain, Technical Component Only

Assessment of MYC expression

MOC31 - Overview: MOC-31 Immunostain, Technical Component Only

Marker of epithelial cells

CONCS - Overview: Contactin-1 IgG Cell Binding Assay, Serum

Evaluating for chronic inflammatory demyelinating polyradiculoneuropathy and related demyelinating peripheral neuropathies Determining contactin-1 IgG results as a part of a profile

HBELI - Overview: Hemoglobin Electrophoresis Interpretation

Interpretation for the results of hemoglobin electrophoresis Diagnosis and classification of hemoglobin disorders, including thalassemias and hemoglobin variants

HAEV1 - Overview: Hemolytic Anemia Evaluation, Blood

Evaluation of lifelong or inherited hemolytic anemias, including red blood cell membrane disorders, unstable or abnormal hemoglobin variants, and red blood cell enzyme disorders This evaluation is not suitable for acquired causes of...

PEWE - Overview: Porphyrins Evaluation, Washed Erythrocytes

Preferred test for analysis of erythrocyte porphyrins Establishing a biochemical diagnosis of erythropoietic protoporphyria, and X-linked dominant protoporphyria

FNMEN - Overview: Neisseria Meningitidis IgG Vaccine Response

Neisseria Meningitidis IgG Vaccine Response

VZPG - Overview: Varicella-Zoster Antibody, IgG, Serum

Determination of immune status of individuals to the varicella-zoster virus (VZV) Documentation of previous infection with VZV in an individual without a previous record of immunization to VZV

BIVAL - Overview: Bivalirudin, Ecarin, Plasma

Monitoring of bivalirudin therapy for patients with prolonged baseline activated partial thromboplastin time

ROXUR - Overview: Oxalate, Random, Urine

Monitoring therapy for kidney stones using random urine specimens Identifying increased urinary oxalate as a risk factor for stone formation Diagnosis of primary or secondary hyperoxaluria

OXU - Overview: Oxalate, 24 Hour, Urine

Monitoring therapy for kidney stones using 24-hour urine collections Identifying increased urinary oxalate as a risk factor for stone formation Diagnosis of primary or secondary hyperoxaluria

MINT - Overview: Molecular Interpretation

Interpretation of the hereditary erythrocytosis profile

BMIYC - Overview: Borrelia miyamotoi Detection PCR, Spinal Fluid

Aids in the diagnosis of Borrelia miyamotoi infection in conjunction with clinical findings This test is not useful for detecting the Borrelia species that cause Lyme disease.

CATN - Overview: Calcitonin, Serum

Aids in the diagnosis and follow-up of medullary thyroid carcinoma Aids in the evaluation of multiple endocrine neoplasia type II and familial medullary thyroid carcinoma This test is not useful for evaluating calcium metabolic...

SCGCT - Overview: Neisseria gonorrhoeae, Self-Collect, Nucleic Acid Amplification, Throat

Detecting Neisseria gonorrhoeae using throat swabs collected by the patient in a healthcare setting This test is not intended for use in medico-legal applications.

SCGCV - Overview: Neisseria gonorrhoeae, Self-Collect, Amplified RNA, Vaginal

Detecting Neisseria gonorrhoeae using vaginal swabs collected by the patient in a healthcare setting This test is not intended for use in medico-legal applications.

MUXF3 - Overview: MUXF3 (Cross-reactive Carbohydrate Determinant), IgE, Serum

Evaluation for the presence of antibodies to cross-reactive carbohydrate determinates (CCD) Investigation of clinically unexpected positive IgE antibody testing in a wide variety of plant and invertebrate allergens

TXM - Overview: Toxoplasma gondii Antibody, IgM, Serum

Detecting recent infection with Toxoplasma gondii

DHRF - Overview: Dihydrorhodamine Flow Cytometric N-Formyl-Methionyl-Leucyl-Phenylalanine Test, Blood

Evaluation of Rac2 deficiency and RAC2 gain of function

CUT - Overview: Copper, Liver Tissue

Diagnosing Wilson disease and primary biliary cirrhosis using liver tissue specimens

BRAFB - Overview: Cell-Free DNA BRAF V600, Blood

An alternative to invasive tissue biopsies for the determination of BRAF V600E and V600K alterations Identification of patients with cancer who are most likely to benefit from targeted therapies This test is not intended for serial...

GLP - Overview: Glucagon, Plasma

Diagnosis and follow-up of glucagonomas and other glucagon-producing tumors Assessing diabetic patients with problematic hyper- or hypoglycemic episodes (extremely limited utility)

SCGCR - Overview: Neisseria gonorrhoeae, Self-Collect, Nucleic Acid Amplification, Rectal

Detecting Neisseria gonorrhoeae using rectal swabs collected by the patient in a healthcare setting This test is not intended for use in medico-legal applications.

PBPFD - Overview: Lead Profile Occupational Exposure, Blood

Detecting lead toxicity due to occupational exposure

CHIMS - Overview: Chimerism Transplant Sorted Cells, Varies

Determining the relative amounts of donor and recipient cells in a specimen in sorted cell fractions An indicator of bone marrow transplant success

CHIMU - Overview: Chimerism Transplant No Cell Sort, Varies

Determining the relative amounts of donor and recipient cells in a specimen An indicator of bone marrow transplant success

MCLBP - Overview: MayoComplete Liquid Biopsy Panel, Next-Generation Sequencing, Cell-Free DNA

As an alternative to invasive tissue biopsies to assist in tumor profiling for diagnosis, predicting prognosis, and identifying targeted therapies for the treatment and management of patients with solid tumors As an alternative to invasive...

FHTGF - Overview: Human Transforming Growth Factor beta 1 (TGF-b1)

Human Transforming Growth Factor beta 1 (TGF-b1)

AGDD - Overview: Alpha Globin Cluster Locus Deletion/Duplication, Varies

Diagnosis of alpha-thalassemia Carrier screening for individuals from high-risk populations for alpha-thalassemia This test is not useful for diagnosis or confirmation of beta-thalassemia or hemoglobinopathies.